186 related articles for article (PubMed ID: 31987977)
1. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
Indelicato DJ; Rotondo RL; Krasin MJ; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):968-976. PubMed ID: 31987977
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
[TBL] [Abstract][Full Text] [Related]
3. 45 GyRBE for group III orbital embryonal rhabdomyosarcoma.
Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Hol ML; Bradley JA
Acta Oncol; 2019 Oct; 58(10):1404-1409. PubMed ID: 31530120
[No Abstract] [Full Text] [Related]
4. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
[TBL] [Abstract][Full Text] [Related]
5. Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis.
Uezono H; Indelicato DJ; Rotondo RL; Mailhot Vega RB; Bradfield SM; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):974-981. PubMed ID: 32437922
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
Chargari C; Haie-Meder C; Guérin F; Minard-Colin V; de Lambert G; Mazeron R; Escande A; Marsolat F; Dumas I; Deutsch E; Valteau-Couanet D; Audry G; Oberlin O; Martelli H
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):352-359. PubMed ID: 28463154
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma.
Ladra MM; Szymonifka JD; Mahajan A; Friedmann AM; Yong Yeap B; Goebel CP; MacDonald SM; Grosshans DR; Rodriguez-Galindo C; Marcus KJ; Tarbell NJ; Yock TI
J Clin Oncol; 2014 Nov; 32(33):3762-70. PubMed ID: 25332253
[TBL] [Abstract][Full Text] [Related]
8. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
9. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
[TBL] [Abstract][Full Text] [Related]
10. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following proton therapy for pediatric ependymoma.
Indelicato DJ; Bradley JA; Rotondo RL; Nanda RH; Logie N; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Mendenhall NP
Acta Oncol; 2018 May; 57(5):644-648. PubMed ID: 29239262
[TBL] [Abstract][Full Text] [Related]
12. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
[TBL] [Abstract][Full Text] [Related]
13. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
Casey DL; Wexler LH; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Med; 2018 May; 7(5):1870-1874. PubMed ID: 29605967
[TBL] [Abstract][Full Text] [Related]
15. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
[TBL] [Abstract][Full Text] [Related]
16. Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients.
Regine WF; Fontanesi J; Kumar P; Ayers D; Bowman LC; Pappo AS; Coffey DH; Avery L; Rao BN; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):485-91. PubMed ID: 7852110
[TBL] [Abstract][Full Text] [Related]
17. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
Hays DM; Raney RB; Wharam MD; Wiener E; Lobe TE; Andrassy RJ; Lawrence W; Johnston J; Webber B; Maurer HM
J Pediatr Hematol Oncol; 1995 Feb; 17(1):46-52. PubMed ID: 7743237
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
19. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Rodeberg DA; Wharam MD; Lyden ER; Stoner JA; Brown K; Wolden SL; Paidas CN; Donaldson SS; Hawkins DS; Spunt SL; Arndt CA
Int J Cancer; 2015 Jul; 137(1):204-11. PubMed ID: 25418440
[TBL] [Abstract][Full Text] [Related]
20. Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy.
Leiser D; Calaminus G; Malyapa R; Bojaxhiu B; Albertini F; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Walser M; Timmermann B; Lomax T; Schneider R; Weber DC
Radiother Oncol; 2016 Jul; 120(1):163-8. PubMed ID: 27247053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
